RadNet (RDNT) Stock Price, News & Analysis

Company Overview

RadNet, Inc. is an outpatient diagnostic imaging company that provides medical imaging services through a network of ambulatory imaging centers. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT), mammography, ultrasound, X-ray, fluoroscopy and other diagnostic examinations.

The company serves patients, physicians, hospitals and health systems, with operations concentrated in several U.S. markets, including California, Delaware, Maryland, New Jersey and New York. RadNet’s centers are designed to provide lower-cost and more convenient imaging alternatives to hospital-based facilities, while supporting referring physicians with radiology interpretation and related clinical services.

RadNet also develops and uses technology for image management, radiology workflow and patient engagement. Through its digital health initiatives, the company has expanded into tools intended to improve scheduling, communication and access to diagnostic imaging. RadNet is led by Howard G. Berger, who has served as the company’s president and chief executive officer for many years.

Key Stats

• Today's Range: $67.80 to $70.68
• 50-Day Range: $61.51 to $77.78
• 52-Week Range: $50.82 to $85.84
• Volume: 574,189 shs
• Average Volume: 811,978 shs
• Market Capitalization: $5.50 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $90.00
• Consensus Rating: Moderate Buy

RadNet Stock Analysis - MarketRank™

RadNet scored higher than 71% of companies evaluated by MarketBeat, and ranked 184th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

RadNet has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 2 strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

RadNet has a consensus price target of $90.00, representing about 28.2% upside from its current price of $70.21.

Amount of Analyst Coverage

RadNet has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 77.55%

Earnings Growth

Earnings for RadNet are expected to grow by 77.55% in the coming year, from $0.49 to $0.87 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of RadNet is -259.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of RadNet is -259.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

RadNet has a P/B Ratio of 3.99. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.95% of the float of RadNet has been sold short.

Short Interest Ratio / Days to Cover

RadNet has a short interest ratio ("days to cover") of 11.93, which indicates bearish sentiment.

Change versus previous month

Short interest in RadNet has recently decreased by 2.71%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

RadNet does not currently pay a dividend.

Dividend Growth

RadNet does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.51

News Sentiment

RadNet has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for RadNet this week, compared to 4 articles on an average week.

Search Interest

Only 2 people have searched for RDNT on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, RadNet insiders have not sold or bought any company stock.

Percentage Held by Insiders

5.14% of the stock of RadNet is held by insiders.

Percentage Held by Institutions

77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 10/02/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:RDNT
• CIK: 790526
• Web: www.radnet.com
• Phone: (310) 478-7808
• Fax: 310-445-2980
• Employees: 11,264
• Year Founded: 1981

Price Target and Rating

• Average Price Target for RadNet: $90.00
• High Price Target: $95.00
• Low Price Target: $79.00
• Potential Upside/Downside: +28.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.89
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.27)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 142.71
• P/E Growth: N/A
• Net Income: -$18.65 million
• Net Margins: -0.93%
• Pretax Margin: 1.54%
• Return on Equity: 2.61%
• Return on Assets: 0.91%

Debt

• Debt-to-Equity Ratio: 0.94
• Current Ratio: 1.48
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $2.04 billion
• Price / Sales: 2.70
• Cash Flow: $3.27 per share
• Price / Cash Flow: 21.38
• Book Value: $17.58 per share
• Price / Book: 3.98

Miscellaneous

• Outstanding Shares: 78,700,000
• Free Float: 74,652,000
• Market Cap: $5.50 billion
• Optionable: Optionable
• Beta: 1.41